First Eagle Investment Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-278,154
Closed -$3.58M 426
2023
Q3
$3.58M Buy
278,154
+27,534
+11% +$495K 0.01% 257
2023
Q2
$4.53M Buy
250,620
+174,655
+230% +$3.26M 0.01% 216
2023
Q1
$1.27M Sell
75,965
-53,150
-41% -$1.04M ﹤0.01% 322
2022
Q4
$2.65M Sell
129,115
-28,983
-18% -$511K 0.01% 222
2022
Q3
$3.02M Buy
158,098
+46,476
+42% +$1.05M 0.01% 144
2022
Q2
$2.63M Buy
111,622
+32,577
+41% +$933K 0.01% 152
2022
Q1
$2.58M Buy
79,045
+39,234
+99% +$1.26M 0.01% 123
2021
Q4
$1.24M Buy
39,811
+30,081
+309% +$1.01M ﹤0.01% 117
2021
Q3
$371K Buy
9,730
+8,500
+691% +$338K ﹤0.01% 170
2021
Q2
$49K Buy
+1,230
New +$52K ﹤0.01% 209

Other funds holding OFIX

First Eagle Investment Management's OFIX Position: Q4 2023 in Review

First Eagle Investment Management sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 278,154 shares — an estimated $3.58M sold.

First Eagle Investment Management first reported a position in OFIX in Q2 2021 and held it in 10 quarters. The position peaked at $4.53M in Q2 2023. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • First Eagle Investment Management reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
  • First Eagle Investment Management sold 278,154 Orthofix Medical shares in Q4 2023, an estimated $3.58M.
  • First Eagle Investment Management first reported a position in Orthofix Medical in Q2 2021 and held it in 10 quarters.
  • First Eagle Investment Management's Orthofix Medical position peaked at $4.53M in Q2 2023.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on First Eagle Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.